Growth Metrics

Dexcom (DXCM) Depreciation & Amortization (CF) (2016 - 2025)

Dexcom (DXCM) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $65.2 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 12.8% to $65.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $251.8 million through Dec 2025, up 15.66% year-over-year, with the annual reading at $251.8 million for FY2025, 15.66% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $65.2 million at Dexcom, up from $63.6 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $65.2 million in Q4 2025, with the low at $20.9 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $45.7 million, with a median of $45.9 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 85.53% in 2022, then increased 0.23% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $32.1 million in 2021, then rose by 13.08% to $36.3 million in 2022, then surged by 44.63% to $52.5 million in 2023, then increased by 10.1% to $57.8 million in 2024, then rose by 12.8% to $65.2 million in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $65.2 million, $63.6 million, and $63.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.